Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.
Remnestål J, Öijerstedt L, Ullgren A, Olofsson J, Bergström S, Kultima K, Ingelsson M, Kilander L, Uhlén M, Månberg A, Graff C, Nilsson P.
Remnestål J, et al. Among authors: nilsson p.
Transl Neurodegener. 2020 Jun 23;9(1):27. doi: 10.1186/s40035-020-00198-y.
Transl Neurodegener. 2020.
PMID: 32576262
Free PMC article.